JBT Marel reported Q4 2025 revenue of USD 1.01 billion and inbound orders of USD 1.04 billion, with Q4 income from continuing operations of USD 53.1 million (5.3% margin), adjusted EBITDA of USD 161.1 million (16.0% margin), and diluted EPS from continuing operations of USD 1.01 (adjusted EPS USD 1.98). For FY 2025, JBT Marel posted revenue of USD 3.8 billion, a loss from continuing operations of USD 50.5 million ((1.3)% margin), adjusted EBITDA of USD 600.4 million (15.8% margin), diluted EPS from continuing operations of USD (0.96) (adjusted EPS USD 6.41), operating cash flow from continuing operations of USD 341.7 million, and free cash flow of USD 249.8 million; year-end backlog was USD 1.37 billion and net debt to trailing twelve months adjusted EBITDA was 2.9x. The company said it achieved record quarterly orders and revenue above USD 1.0 billion in Q4, realigned reporting segments to Protein Solutions and Prepared Food and Beverage Solutions, realized approximately USD 43 million in FY 2025 year-over-year synergy savings (USD 85 million annualized run-rate exiting 2025), and established FY 2026 guidance for revenue of USD 3.99–4.07 billion (5%–7% growth, including ~1% FX benefit), income from continuing operations margin of 6.1%–6.6%, adjusted EBITDA margin of 17.0%–17.5%, GAAP EPS of USD 4.70–5.15, and adjusted EPS of USD 8.00–8.50.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JBT Marel Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202602231620BIZWIRE_USPR_____20260223_BW012875) on February 23, 2026, and is solely responsible for the information contained therein.